




PULMONARY PATHOLOGIES FOLLOWING INHALATION OF MULTI-WALLED 




Marshal Anthony Phipps, Jr. 
 
Director of Thesis: Dianne M. Walters, Ph.D. 
 
Home Department:  Department of Biomedical Science 
  
Multi-walled carbon nanotubes (MWCNT) are a nanomaterial that is growing in use and 
popularity. The health effects of occupational pulmonary exposure to MWCNT are 
currently unknown. The goals of this study were to build a dust generator capable of 
producing occupational levels of MWNCT and to examine pulmonary effects of 
occupational levels of inhaled dry MWCNT. We designed, built, and tested a dust 
generator capable of producing MWCNT concentrations in the occupational exposure 
range (25,000 to 50,000 particles/cm3). In a time course study, C57BL/6J male mice 
were exposed to either a dust of MWCNT at a daily average of approximately 37,000 
particles/cm3 and a daily peak of about 50,000 particles/cm3 or to air alone. Six mice per 
group were exposed for 4 hours per day for 5 days a week for 2 weeks and sacrificed 1, 
3, 7, 10, 14, 28, and 84 days post-exposure. In a strain comparison study DBA/2J and 
A/J mice underwent the same exposure and were sacrificed at 14 days post-exposure. 
For both studies bronchoalveolar lavage (BAL) fluid was collected to assess cellular 
profile and protein content. The right lung was used for collagen measurement. The left 
lung was used for histological evaluation. Total protein, a measure of lung permeability, 
did not change significantly after MWCNT exposure compared to air controls at any time 
point. Likewise, eosinophil and neutrophil cell counts were not significantly different 
 
 
between air and MWCNT-exposed mice. However, compared to air controls, MWCNT-
exposed mice had increased numbers of total cells and macrophages at 28 days post 
exposure and increased monocytes from 10 to 14 days exposure. The presence of 
MWCNT was visually noted in BAL cell pellets, histology slides, and lung homogenate 
membrane pellets at all of the time points. Dark field microscopy showed MWCNT in 
BAL cells at all of the time points in MWCNT exposed mice. Collagen levels were not 
different between exposure groups at any time point. The strain comparison found that 
C57BL/6J mice had increases in monocytes and lymphocytes at 14 days post exposure 
and A/J mice showed a trend towards an increase in lung protein levels in MWCNT 
exposed mice at 14 days post exposure. MWCNT were visually detected in lung 
homogenate membrane pellets and in the histology slides from all strains. Although 
short-term inhalational exposure to occupationally relevant levels of dry dusts of 
MWCNTs did not elicit significant increases in measures of lung injury or fibrogenesis, 
increases in mononuclear cells and lack of particle clearance may indicate an altered 
host-defense capacity which could lead to disease with further particle accumulation or 
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1.1 PROBLEM AND APPROACH 
Carbon nanotubes (CNT) are a nanomaterial being used, or proposed for use, in 
a wide variety of commercial and biomedical applications due to their unique properties 
such as small size, chemical reactivity, strength, biocompatibility, and electrical, 
thermal, and magnetic capabilities. Because of their extensive applicability, human 
exposure to CNT is inevitable, yet little is known about their safety. Even though to date 
there have been no reports of human disease associated with exposure to CNT, their 
toxicity to humans is unknown. Pulmonary toxicity is particularly worrisome since CNT 
have a structure similar to that of asbestos, which is known to result in lung diseases in 
humans and can present decades after the initial exposure. Given that nanotubes were 
only recognized in 1991 [1], there may not have been adequate time for the human 
health impact to have been recognized. While the full effects of CNT on human 
pulmonary tissue are unknown, animal studies to date indicate that pulmonary exposure 
to CNT can induce inflammation [2-5], granulomas [6-8], and tumors [9]. However, most 
studies on the impact of CNT have used non-physiological delivery methods. 
Additionally, the doses administered to date have been markedly higher than doses that 
are encountered ambiently or in occupational settings. Thus, there is a need for studies 
that evaluate the health effects of multi-walled carbon nanotubes (MWCMT) within an 
occupationally relevant range. In this study we designed, developed, and tested a 
nanotube dust generation system capable of delivering occupational levels of 
nanomaterials to evaluate the impact of MWCNT on the lungs of mice. Validation of the 
 
2 
delivery system was conducted to enable the second aim of identifying MWCNT-
induced lung pathologies and investigating the mechanisms through which lung disease 
may be induced by inhalation of occupational levels of MWCNT. 
1.2 BACKGROUND 
1.2.1 CARBON NANOTUBES 
 CNT are a type of nanoparticle, which are also called ultrafine particles or 
nanosized particles. Ultrafine particles are nanoparticles that occur naturally while 
nanoparticles typically refer to engineered particles. By definition, these particles have 
dimensions smaller than 100 nanometers (nm) in one dimension. The small size of 
nanoparticles results in both a large surface area compared to their mass/volume and 
high particle concentration rates. Because of their small size, nanoparticles can enter 
the human body via inhalation, ingestion, or absorption and can translocate into the 
blood or lymphatic system [2, 10]. Once in the blood or lymph, nanoparticles can 
distribute to other organs such as the heart, spleen, and central nervous system. The 
size, surface area (which increases as the size decreases), and bioactivity give 
nanoparticles properties which can result in either negative or positive biological effects 
including inflammation, oxidative stress, antioxidant activity, the ability to penetrate cell 
membranes and thus deliver drugs, etc. The activity could also include a combination of 
positive and negative effects [2]. Nanoparticles can occur naturally from volcanoes or 
fires, unintentionally from drilling or welding, or from manufacturing or engineering 
processes intended to create them for use in various products. Created or engineered 
nanomaterials can be manufactured in a variety of formats and as such offer attractive 
development potential [11]. Manufactured nanoparticles are generally identified based 
on their shape and include nanotubes, nanorings, nanofibers, nanowires, etc. [2] Fiber-
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like nanoparticles can occur singly or in ropes or clumps and may be partially rigid, 
partially flexible, or rigid [12]. Engineered nanoparticles can be made of elements such 
as carbon but also of lipids, chitosan, silica, lactic acid, metals. The source material 
impacts the properties of the nanoparticles [13].  
 Carbon nanotubes are the specific focus of this study. They are an allotrope of 
carbon from the fullerene family typically characterized as either single walled carbon 
nanotubes (SWCNT) or multi-walled carbon nanotubes (MWCNT). The tubes are 





Figure 1.1: Carbon Nanotube Structure. Diagram of a single-walled carbon nanotube 
(SWCNT) and a multi-walled carbon nanotube (MWCNT) demonstrating the cylindrical 










 Carbon nanotubes were first observed in the late 1950s by Roger Bacon while 
working with carbon fiber and again in the 1970s by Morinobu Endo while working with 
a gas phase process. In 1991, Sumio Iijima found multiwall carbon nanotubes in a 
carbon arc discharge. Two years later he and Donald Bethune independently observed 
single walled carbon nanotubes (buckytubes) [1, 15] after which research in the field 
rapidly expanded. Carbon nanotubes are stronger than steel, can function as metals or 
semi-conductors, are thermally conductive, can be functionalized, and are considered to 
be one dimensional. 
 Given the wide array of potential uses for carbon nanotubes, multiple methods to 
produce them arose. Each method has advantages and disadvantages and produces 
products with varying degrees of purity [16]. Manufacturing of carbon nanotubes can be 
done via physical processes (arc discharge or laser ablation), chemical processes 
(chemical vapor deposition, high pressure carbon monoxide reaction also known as 
HiPco®, or CoMoCAT®) or miscellaneous processes (helium arc discharge, 
electrolysis, flame synthesis). The three most common methods are arc discharge, laser 
ablation, and chemical vapor deposition. Key considerations for the manufacturing 
method chosen include cost on a per unit basis, the availability of raw materials, the 
amount of energy needed, the design of the reactor, the rate at which production can 
occur, the product purity, the product yields, the amount of post-production processing 
that is required, and the type of processing that can be done, i.e. batch versus 
continuous. All three methods can produce pure carbon nanotubes. Both laser ablation 
and chemical vapor deposition can both produce relatively high yield. However when 
taking all factors into consideration chemical vapor deposition best meets the previous 
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considerations, i.e. low cost per unit, no extensive post production refinement needed, 
easy availability of raw materials, etc. [17]. In spite of the advantages chemical vapor 
deposition does produce contaminants that have to be removed to ensure purity. This 
removal can be costly and uses processes that can shorten the CNT and/or introduce 
defects in the sidewalls of the CNT. Improvement on current production methods, as 
well as development of new methods of production and alteration of CNT, is the subject 
of intense research and commercial interest. Production in 2013 exceeded several 
thousand tons of nanotubes per year [18, 19] and is expected to grow over the decade 
beyond 2013 [20].  
1.2.2 USES OF CARBON NANOTUBES 
 Nanotubes, both SWCNT and MWCNT, have current and proposed 
uses in both commerce and healthcare with higher current use in commercial 
areas than in health care. Due to their high aspect ratio and strength carbon 
nanotubes are used as fillers in plastics, in composite materials, in thin films, 
and in resins. Their conductivity makes them useful  in the automotive 
industry for electrostatic painting and in fuel lines to deplete electrical 
charges. MWCNT are added to polymers and resins as strengthening 
components, and are particularly useful in boat hulls and turbine blades due 
to their stiffness. Because of the material damping features of MWCNT they 
are used in tennis rackets, bicycles, and baseball bats where oscillation is a 
negative feature. Due to their conductivity, carbon nanotubes are commonly 
used in lithium ion batteries for laptops and cell phones as well as in 
transistors and semiconductors. The structure of carbon nanotubes may also 
mean they can be used for water purification by taking advantage of tangled 
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CNT to electrostatically remove bacteria, viruses, and other contaminates  
[18]. 
 A key feature of CNT for biomedical applications is that they can be 
functionalized which can remove bioactivity [21] and, in conjunction with their small size, 
allow for uses such as delivery of medications to precise locations including the lungs. 
They have many other potential uses in medical settings, such as in rehabilitative 
medicine for engineering tissues, imaging, diagnosing diseases, and/or texturing 
surfaces [22]. They can be used in the monitoring and treatment of diseases such 
cancer and/or infections [23] and as a means of transporting genetic material or 
peptides to cells [24]. Furthermore, CNT can be used for tissue regeneration 
(particularly bone tissue through scaffolding), for cardiovascular applications, and for 
chemotherapy both by way of drug delivery and by way of phototherapy [25]. Finally, 
they can also be used for biomedical sensors from both the standpoint of their size and 
chemical compatibility [18].  
 The goal of functionalization is to allow utilization of carbon nanotubes in 
practical ways while minimizing any potential toxic impacts of the very properties that 
allow for their use in biomedical applications. Functionalization methods include binding 
proteins to the CNT, covalent purification, non-covalent surface modifications, 
attachment of DNA, polyethylene glycol, chitosan, or surfactants, or combinations of 
these methods [25]. Functionalization can also be used to mimic the properties of 
naturally occurring micro-tubes which share multiple properties with carbon nanotubes 
and are simultaneously stiff and resilient and which provide essential cell functionality 
including transport and motility [26]. Massive amounts of research and investment have 
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been targeted at practical uses of carbon nanotubes, however a number factors that 
make nanotubes unique (aspect ratio, biopersistence, and residual metal content), and 
therefore allow for this type of functionalization, may also lead to toxicity thus requiring 
careful attention to determining the toxicity of carbon nanotubes and minimizing the 
potential negative impacts [22]. A first step in minimizing adverse health effects is to 
understand the toxicity of CNT through the expected routes of exposure such as 
inhalation.  
1.2.3 OCCUPATIONAL EXPOSURE TO CARBON NANOTUBES 
 Inhaled dust is a serious occupational risk that can result in injury and chronic 
lung disease [27]. The risk to workers for occupational exposure to CNT occurs during 
production and/or handling of the materials. Exposure can also occur when nanotubes 
are prepared for use or actually used for drug delivery [28]. Even though a field study of 
exposure rates showed both lower concentrations of particles in the air and on gloves 
than anticipated based on laboratory studies [29], workers are exposed to CNT. In 2011 
sixty-one companies were manufacturing carbon nanotubes in the United States 
employing 620 workers with a predicted annual growth rate of 15-17% [30].  
 Given the potential for negative health effects resulting from exposure to 
MWCNT, it is important to study this in order to implement safety guidelines. Wide 
ranges of values have been found for occupational exposures that depend on the 
factory where they are made as well as the manufacturing processes used. A National 
Institute for Occupational Safety and Health (NIOSH) team visited multiple 
manufacturing plants and developed a tool to assess exposure. The nanoparticle 
emission assessment technique (NEAT) was used to determine the inhalation exposure 
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via air samples while not accounting for incidental exposures [31]. A follow up study by 
NIOSH used this technique at twelve sites making a variety of nanomaterials including 
both SWCNT and MWCNT and found that in some conditions workers could be 
exposed to over 42,000 particles/cm3 below 1000 nm but also found that existing 
engineering controls could minimize exposure [32]. A study conducted at a Swiss plant 
that manufactures nanoparticles found an average concentration of nearly 60,000 
particles/cm3 and a peak of 136,000 particles/cm3. Of note this study took all phases of 
manufacturing into consideration, i.e. producing, maintaining, and handling the 
nanomaterials [33]. Monitoring by a variety of methods at a manufacturing and 
processing plant for carbon nanofibers found elevated particle concentrations related to 
ultrafine particles released during a thermal treatment but did find short term increases 
in particles that could be inspired at a rate of 1.1 mg/m3 during handling of the carbon 
nanofibers [34].  
 Based on available research, NIOSH proposed a recommended exposure limit 
(REL) for CNT at a level of 7 µg/m3 of elemental carbon for respirable particles. This is 
an 8 hour time weighted average using elemental carbon as a marker for exposure to 
CNT. This limit was exceeded in two of three plants tested [35].  Occupational 
monitoring showed exposure to carbon nanotubes most commonly occurred when 
opening the chemical vapor deposition cover and when working with various catalysts 
[36]. Implementing environmental control measures at a laboratory using MWCNT 
significantly decreased the numbers found in samples [37]. Control methods other than 




 Of particular concern with nanotubes in occupational settings is that their length 
may increase the toxicity, the needle-like shape may mimic the impact of asbestos 
fibers, and they are biopersistent. Although CNT are typically purified after manufacture, 
they may still contain metals, organic, and/or other support materials. The common 
metals used are copper, iron, nickel, and molybdenum or a mix of these metals. CNT 
are frequently chemically modified to accomplish goals such as increased solubility. 
CNT can also be coated. The toxic impact of the carbon nanotubes is a product of the 
surface area and the toxicity of the surface. Of concern in the workplace are things that 
can be inhaled (< 10 µm aerodynamic diameter) meaning they can enter the human 
respiratory tract and things that can be respired (< 4.5 µm aerodynamic diameter) 
meaning they can get beyond the ciliated airways. Of additional concern is the need to 
determine methods to measure these very small particles [12]. Another study that 
exposed mice with the goal of mirroring the exposure rates found in eight manufacturing 
plants showed variation in deposition rates but limited inflammatory response [39].   
1.2.4 TOXICOLOGICAL PROPERTIES OF CARBON NANOTUBES 
 In addition to the many current and proposed uses for CNT, there are an equal 
number of concerns about their safety and possible toxicity. As manufacturing and use 
of carbon nanotubes increases, so does the potential for human exposure. Key 
concerns related to the potential toxicity of carbon nanotubes include their physical 
properties (small size, large surface area, aspect ratio, etc.) and their chemical 
properties, as well as any contaminants from either manufacturing or functionalization 
processes. Other toxicological factors include route of exposure (dermal, inhalation, 
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ingestion, or injection), dose and duration of exposure, biopersistence, and aggregation 
of the nanotubes [40-42]. 
 Multiple studies have discussed the similarities of CNT to asbestos in which 
pulmonary retention of fibers results in injury and inflammation followed by chronic lung 
pathology, specifically mesothelioma and fibrosis. Pertinent toxicity factors include the 
long length of the asbestos fibers so that they cannot be consumed completely by 
alveolar macrophages, the thin diameter allowing movement beyond the airways and 
lung tissue, and their biopersistence leading to dose accumulation. Similar to asbestos 
fibers, inhalation of CNT, which can occur as tangles or longer fibers, can lead to 
incomplete consumption by macrophages resulting in inflammation [43], oxidative stress 
to the lungs [40], granulomas in the presence of long MWCNT, and in some cases a 
systemic response which could impact the cardiovascular system [44]. Furthermore, 
similar to asbestos, carbon nanotubes can be translocated into other organs and tissues 
via either the lymphatic system or cellular migration. Asbestos and carbon nanotubes 
both demonstrated cellular toxicity, DNA damage, fibrosis, and malignant mesothelioma 
via peritoneal exposure [6, 45]. Additionally, both fibers induced expression of genes 
related to mesothelioma and to lung cancer [46].  
 Of additional concern is the long lag time from asbestos exposure to disease, 
which can be 15 to 40 years. The disease can not only impact those who mine asbestos 
but those who work with it when it is used as a fire retardant or in construction, those 
who contact things contaminated by asbestos, and even spouses of people who work 
with asbestos. Smoking and genetics also play a role in asbestos related diseases [47]. 
At this time it is unknown whether exposure to CNT will result in the same outcome as 
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asbestos exposure, but given the observed similarities between CNT and asbestos, it is 
a possibility. Therefore, there is a need to understand CNT toxicity so that adverse 
outcomes can be prevented, whether through engineering safer nanotubes or through 
protective strategies, regulation of nanomaterials, and guidelines for exposure limits. 
Key concerns related to the potential toxicity of carbon nanotubes that need to be 
addressed include their physical properties (small size, large surface area compared to 
their size, aspect ratio, etc.) and their chemical properties as well as any contaminants 
that may be present from either the manufacturing or the functionalization process. 
Other factors include realistic exposure scenarios, the route of exposure (dermal, 
inhalation, ingestion, or injection), the dose and duration of the exposure, the 
biopersistence of the nanotubes, and the aggregation of the nanotubes [40-42].  
 Many rodent studies have been done with instillation or aspiration of MWCNT, 
but occupational exposure is far more likely to occur via inhalation which was shown in 
mice to result in different lung pathologies attributed to different sizes, different 
diameters, and distribution patterns of aggregation of the MWCNT [48-50]. The 
dustiness of different MWCNT may be an important occupational factor since exposure 
of mice to inhaled, low dust forming MWCNT showed minimal granuloma inflammation 
and only slight neutrophilia [51]. Volumetric lung burden correlated with toxicity and 
following species adjustments suggests an occupational exposure limit (OEL) of 0.05 
mg Baytubes/m(3) for humans [52]. A two week study using whole body inhalation with 
rats demonstrated deposition of MWCNT in both the nasal cavity and lungs with 
clearance shown from the nasal cavity. Like multiple other studies this study also 
showed dose dependence, migration of MWCNT via the lymphatic system, granuloma 
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formation at the highest doses, and persistence of the carbon nanotubes. This study 
established a no observed adverse effect level (NOAEL) for rats of 0.2 mg/m(3) for two 
weeks however the biopersistence could have led to problems even at this dose had the 
study gone on longer [53]. Purity also matters as a study of long term pristine MWCNT 
exposure in A549 human cells showed no major long term effects or induced adaptive 
mechanisms [54]. As described above many studies have been done looking at the 
impact of carbon nanotubes, however many of these studies were done using aspiration 
or tracheal installation, neither of which is a physiological mechanism. 
 In addition to inflammation and fibrosis, studies also showed biopersistence of 
carbon nanotubes. Rats administered MCWCNT via whole body inhalation showed a 
decrease in the amount of retained MWCNT at three months with dose dependent half 
times occurring at 51 and 54 days [55]. Even sub-chronic doses of MWCNT 
demonstrated biopersistence when given to rats via nose only exposure and was dose 
dependent, showed translocation to lymph nodes at the two highest doses, and also 
demonstrated that MWCNT aggregated into bundles known as assemblages. The 
assemblages, which aggregated in the alveoli and were consistently retained in the 
alveolar macrophages, are intertwined and coil like structures that could then form 
clumps. The assemblages themselves appeared to result in the toxicity as opposed to 
some other factor. When compared with carbon black, both carbon black and MWCNT 
resulted in the same type of triggering response but the MWCNT based on BAL 
analysis were more toxic which was believed to be due to the high displacement volume 
caused by the assemblages of MWCNT [56]. A study using this same type of MWCNT 
delivered by both dry and wet dispersion to rat lungs showed biopersistence at three 
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months for both, but with wet dispersion being at levels three times higher than dry 
dispersion when analyzed by both dosimetry and electron microscopy [57]. Exposure of 
nicotinamide adenine dinucleotide phosphate (NADPH) oxidase-deficient mice to 
SWCNT showed bioperistence but also decreased fibrosis thus indicating that NADPH 
oxidase is necessary to regulate apoptosis and allow for a move away from acute 
inflammation [58]. When unrespirable agglomerates of MWCNT were administered via 
instillation, there was evidence of apoptosis but not of other toxic effects [59]. In another 
study, MWCNT caused oxidative stress in rat epithelial cells along with apoptosis [60].  
 Multiple studies compared the effect of carbon nanotubes prepared in various 
ways and with various properties, doses, and the inhalation of other materials. Rats 
exposed one time via inhalation to either air, quartz (a positive control known to be 
toxic), or MWCNT demonstrated dose dependence not impacted by residual cobalt thus 
indicating the toxic impact was from the assemblage of the carbon nanotubes and not 
due to any impurities inherent in the MWCNT [61]. Toxicity in mice lungs was shown to 
be dose dependent using low, medium, and high occupational inhalation doses resulting 
in persistent inflammation and cell toxicity at the high dose, transient cell toxicity at the 
medium dose, and low-grade inflammation at the low dose [39]. Toxicity as measured 
by inflammation and cytokine release in mice pulmonary tissue increased with the 
diameter and length of MWCNT which impacted lung retention as well as dose, but 
were not significantly impacted by either purification or functionalization [21, 62]. In 
addition histopathology of mouse nose tissue following MWCNT administration also 
showed toxic effects including hyaline droplet formation and neutrophilic rhinitis [63]. 
Even at sub-chronic inhalation rates carbon nanotubes resulted in pulmonary 
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inflammation and fibrosis in rats [64]. MWCNT also could both penetrate and persist in 
alveolar macrophages, the alveolar wall, and pleura [65] for a prolonged period after 
exposure [66].  Furthermore, MWCNT could be found not only in lung tissues but also in 
the parietal pleura, respiratory muscles, heart, kidney, and brain almost a year after 
exposure [67]. Pleural presence was also demonstrated in prolonged exposure to 
MWCNT [10]. In human lung epithelial cells a study with various metal oxides showed 
variations across multiple oxides but a significant difference with copper oxide (CuO) as 
well as toxicity attributed to MWCNT [68]. Another study found no acute toxicity but did 
find time and dose dependent ROS and a decrease in the mitochondrial membrane with 
unpurified SWCNT thought to be the result of trace metals [69]. Nose exposure of rats 
showed no toxicity from similar lung volumes of carbon black or graphite nanoplatelets 
but did demonstrate toxicity via BAL analysis and microscopic evaluations from 
graphene and MWCNT with the MWCNT inducing toxicity at a significantly lower dose 
than the graphene. Given the insufficiency of any impurities to induce these effects, the 
toxicity was attributed to either a combination of factors or other unknown factors [70].  
1.2.5 PATHOLOGY RELATED TO CARBON NANOTUBES 
Introduction 
 Although CNT exposure has not been associated with human disease to date, 
animal studies suggest that CNT exposure can produce adverse health effects.  
Specific studies showed that exposure of mouse mesothelial lining of the abdominal 
cavity to long MWCNT produced inflammation and granulomas similar to that produced 
by asbestos [71]. MWCNT administered intraperitoneally to mice in different doses 
produced mesotheliomas [72] at a higher rate and with worsening severity with 
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increased doses; however even mice given the lowest of three doses resulted in 
microscopic precursors to mesothelioma when followed long term [73]. Asbestosis is 
known to worsen among workers with longer exposures whether from asbestos 
manufacturing, from asbestos removal, and/or exposure concomitant with smoking [74, 
75]. Production of both carbon nanotubes and carbon nanofibers may result in similar 
worker exposure via inhalation during multiple phases of production including making, 
purifying, handling and transporting nanomaterials. Asbestos is a natural silicate, while 
the nanomaterial of concern (MWCNT) is artificially produced. Nevertheless, these 
materials have a similar shape, size, and biopersistence (the presence of fibers retained 
in the lungs). Parallels between asbestos and carbon nanotube exposures in mice have 
been drawn in terms of their biological effects on macrophages, and additional cells 
such as lymphocytes, eosinophils, multinucleated giant cells, and neutrophils, and 
granuloma formation. Asbestos exposure can result in plaque formation, asbestosis, 
mesothelioma, and/or lung cancer. Multiple studies have shown a clear correlation 
between asbestos exposure and the development of lung disease with sex (male), age 
(older), smoking, and length of exposure increasing the risk [76, 77]. While mouse 
models have raised concern that carbon nanotubes can similarly induce fibrosis and 
potentially lung cancer, some studies have failed to show toxicity [42].  
 Multiple studies demonstrated that the size of the nanotubes, particularly the 
length, affects toxicity. Direct injection of long carbon nanotubes or asbestos into the 
pleural space of mice resulted in increased granulocytes, increased protein, increased 
mesothelial cells, and fibrosis as opposed to short tubes. The same study investigated 
the injection of beads greater than 10 µm and found that they failed to exit via the 
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stomata and led to inflammation, whereas smaller beads exited the stomata and did not 
elicit inflammation [78]. A related study using aspiration of carbon nanotubes also 
demonstrated length dependent inflammation in that inflammation occurred with long 
carbon nanotubes but not short or tangled carbon nanotubes [3]. Nagai, et al, 
demonstrated that thin, rigid carbon nanotubes’ needle-like structure could penetrate 
the membrane of mesothelial cells (believed to be a different mechanism than asbestos) 
but showing the same deletion of tumor suppressing genes as asbestos [79].  
 Carbon nanotubes with smaller diameters demonstrated more cytotoxicity related 
to cell internalization of the carbon nanotube whether the nanotube was inhaled, 
ingested, or passed through the skin [80]. Others found that fibers that were long and 
thin could not be disposed of via phagocytosis and when implanted in rats for as long as 
a year resulted in malignancies [81]. The length of the MWCNT determined the type of 
bioactivity in both rodent and human alveoli [82]. SWCNT instilled by way of the trachea 
showed more toxicity than carbon black and in some cases more than quartz, a known 
fibrogenic material. The biopersistence and high aspect ratio determined the degree of 
toxicity [83]. MWCNT also showed genetic toxicity via the induction of micronuclei (MN) 
in lung cells via both DNA breaks and chromosomal loss, possibly as their size allowed 
for interaction with molecules dimensionally similar to DNA [84]. 
Induction of Inflammation 
 Multiple studies with carbon nanotubes showed that they can induce pulmonary 
inflammation. Studies measured inflammation in a variety of ways including cytokines, 
differential cell counts, etc., however with various interpretations including that some 
inflammation offered some protection [4] and that release of cytokines led to decreased 
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oxidative stress [85]. Other studies showed a range of reactions including a single 
exposure to MWCNT resulting in inflammation and oxidative stress [5], inflammation 
that progressed over time [63], and not only lung inflammation but possible systemic 
inflammation [86]. In contrast, biodegraded SWCNT aspirated into mice lungs did not 
cause inflammation [87] while non-biodegraded double walled carbon nanotubes 
invoked an inflammatory response very similar to asbestos [88]. Both purified ground 
carbon nanotubes and MWCNT resulted in inflammation, fibromas, and the production 
of TNF-α, a cytokine involved in acute systemic inflammatory reactions [89]. Increased 
doses of MWCNT showed increased inflammation, fibrosis, and even the rare 
translocation of the MWCNT to the lymph system [10]. Mice exposed only to nose only 
inhaled SWCNT and MWCNT developed inflammation, fibrosis, changes in both oxidant 
and antioxidant levels, and apoptosis proteins [90]. A comparison of pristine and 
functionalized MWCNT injected intra-tracheally in rats showed inflammation and toxic 
effects for both [91].  
Pulmonary Fibrosis 
 As noted, pulmonary fibrosis is a common feature of particle deposition and is 
impacted by both the size and composition of the particles. This fibrosis can lead to 
other pathology and/or can worsen existing problems such as asthma. Smaller particles 
have a larger surface area, an increased ability to generate reactive oxygen species 
(ROS), and an increased ability to cause inflammation. The presence of other 
compounds in particles, particularly transition metals such as vanadium or copper, can 
induce cell signaling and therefore oxidative stress [92]. MWCNT can result in early lung 
fibrosis that is dependent upon the dose and time as well as being notable for increased 
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neutrophils, macrophages, cytokines, and growth factors related to fibrogenesis [93]. 
Human lung cell cultures exposed to MWCNT showed ROS production, cytokines which 
are inflammatory markers, and myofibroblast changes believed to be necessary for the 
development of fibrosis [94]. A study of rats given one aspiration dose of SWCNT did 
not show inflammation but did show fibrotic alveolar lesions [95].  
 As previously noted, carbon nanotubes can cause ROS which can activate 
transcription factors and signaling pathways that result in fibrosis. Both short and long 
SWCNT induced oxidative stress but long SWCNT resulted in a more pronounced ROS 
than short SWCNT did, possibly due to the length of the tubes resulting in the 
phagocytes being unable to completely consume the SWCNT (frustrated phagocytosis). 
Both short and long SWCNT resulted in activation of transforming growth factor-beta 
(TGF-β) which stimulates the production of collagen by the fibroblasts but the long 
SWCNT resulted in a significantly stronger response [96]. Aspirated MWCNT were seen 
with the distribution decreasing from the alveolar macrophages to the alveolar septa to 
the sub-pleural tissues resulting in fibrosis [97]. Pleural distribution of MWCNT was also 
seen when mice were given four different doses of MWCNT and then tested with 
bronchoalveolar lavage (BAL) at four different intervals. Inflammation and damage was 
seen in all cases but was dose dependent with rapid onset of fibrosis, persistent 
inflammation, and MWCNT in the pleura [98]. Aspirated SWCNT in mice demonstrated 
similar inflammation and fibrosis but also showed early granulomas, elevation of 
cytokines, production of TGF-β1, alveolar thickening, respiratory deficits, and a 
decrease in bacterial clearance in the lungs but no engulfment of the SWCNT similar to 
other studies with SWCNT [7].  
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Carcinogenic Effects of Carbon Nanotubes 
 Carcinogen related effects of carbon nanotubes include demonstrated DNA 
damage from SWCNT in as little as three hours after exposure [99] including the 
induction of DNA destabilization [100] or modification [101], and potential 
carcinogenicity [102]. Carcinogenicity related to MWCNT may be modified by the tube 
diameter, tube length, tube rigidity, and/or the presence of any surface modifications of 
the tubes [103]. Other carcinogenic impacts include mitotic spindle disruption at 
occupational levels of exposure [104] with the potential to pass that disruption to 
daughter cells [105], centrosome disruption with aneuploidy which is characteristic in 
cancer progression [106-108], sub pleural fibrosis [109], and lung adenomas. 
Adenomas were found at a 90.5% tumor rate and a 5.5% metastasis rate for mice 
receiving an initiator followed by MWCNT exposure, indicating that the MWCNT are 
acting as promotors [9]. Both MWCNT, nanosized titanium oxide, and soot induced 
micronuclei [110], as well as ROS generation and apoptosis in human lung epithelial 
A549 cells [111-114] . Of note, heating reduced the genotoxicity of MWCNT while 
grinding the heated material restored its genotoxicity [84]. Additionally, dispersion of 
SWCNT in dipalmitoylphosphatidylcholine, a major component of pulmonary surfactant, 
resulted in increased ROS while fetal calf serum decreased the oxidative stress [115]. 
Alternately, a longitudinal study failed to demonstrate a carcinogenic response. In this 
study, rats received peritoneal injections of either MWCNT with or without known 
defects, or of a known carcinogen, or of a negative control substance. After two years, 
the rats injected with the known carcinogen developed mesothelioma but none of rats 
injected with other materials did at a rate that could be explained by those materials. 
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These somewhat surprising results were attributed to the relatively short MWCNT that 
were used, the non-sustained inflammatory reaction, and/or to the lack of free radicals 
produced by the nanotubes that were used [116]. 
Other Impacts of Carbon Nanotubes 
 Additional impacts of MWCNT include granuloma formation with T cell and 
macrophage infiltration, an increase in osteopontin [117], and the induction of Twist1 
expression in mouse BAL cells, similar to that seen in human samples obtained from 
sarcoidosis patients [118] with risk factors such as exposure to wood fires, firefighting 
and/or fireplaces which may contain environmental carbon nanotubes [119].  
 Cardiovascular impacts following intra-tracheal instillation of MWCNT included 
elevated heart rate and abdominal arterial lesions in hypertensive mice [120] and 
increased susceptibility to cardiac ischemia or reperfusion injury even in the absence of 
lung inflammation [44].  Other studies found an increase in serum cytokines and 
inflammatory gene expression in blood [121, 122]. Inhalation of MWCNT had a 
persistent impact on the coronary arterioles with impairment of endothelium-mediated 
vessel dilation.  
 Suppression of the systemic immune response persisted for a month following 
exposure to MWCNT [123]. This occurred in the absence of lung changes, but with 
evidence of splenic involvement which may indicate that MWCNT can reach the 
circulatory system [124, 125]. [126]. Impaired lymphatic clearance is dependent upon 
the size and shape of the nanomaterial. Fibers with a diameter less than 3 μm or with a 
length greater than 15 μm showed biopersistence and therefore had the most potential 
for toxic effects [127]. MWCNT delivered to rat lungs via installation also impacted the 
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liver and kidneys resulting tubular necrosis and interstitial nephritis [128]. Dermal 
exposure to MWCNT  at varying doses and exposure times showed their presence in 
epithelial cells [129]. MWCNT in human skin cells also resulted in cell pathway 
disruption, cell cycle arrest, and apoptosis [133]. 
 MWCNT delivered to mouse lungs via aspiration resulted in impaired pulmonary 
function including decreased lung compliance [130]. Length of exposure also mattered 
as a 30 day exposure in mice showed no obvious pathology but a 60 day exposure 
resulted in significant pathology [131]. A multi laboratory comparison study showed 
similar potency and effects using mice and rats and both aspiration and instillation 
although there was variability in neutrophilia [132].  
 The wide range of problems caused by nanomaterials are attributed to their size, 
which by definition must have one dimension less than 100 nanometers (nm), but also 
may be a result of other properties including the surface area, generation free radicals, 
crystal structure, coatings, preparation method, purity, and/or ability to aggregate [28, 
134, 135]. A comparison of pristine MWCNT to acid treated MWCNT showed that both 
induced reversible granulomas, but the pristine MWCNT granulomas took longer to 
resolve [8].  
1.3 SIGNIFICANCE/IMPACT 
 In spite of massive amounts of research and development in the field of 
nanomaterials, there remains much that is unknown about the safety of exposure to 
MWCNT. Most toxicity studies to date have been conducted using exposure methods 
that do not occur in occupational settings, i.e. instillation or aspiration of CNT as 
opposed to inhalation. These methods bypass the natural protective mechanisms of the 
 
24 
respiratory tract and also deliver a larger bolus dose (massively larger in many studies) 
than would occur at a given time in the workplace. The majority of studies to date have 
also been done using a single strain of mice, thus any effects of different genetic 
makeup will not be seen in those studies. This study was designed to address several 
questions left unanswered by others, including development of pulmonary toxicity 
associated with physiological inhalation exposure to occupational concentrations. This 
study will also provide data that may be used to set regulatory guidelines related to 
MWCNT exposure in order to prevent later public/occupational health outcomes as 
occurred with the widespread use of asbestos.  
1.4 HYPOTHESIS AND AIMS 
 Based on the physical and chemical properties of MWCNT there is concern 
about adverse health effects with human inhalational exposure. Workers who are 
exposed to a dry dust of MWCNT may be at risk for toxic effects similar to those of 
asbestos. Studies of the pulmonary effects of MWCNT in rodents have found negative 
health effects; however, most of these studies have not been done at occupational 
levels or through a physiological route. For this reason, study of occupational levels 
through natural inhalation exposure is warranted.  
1.4.1 HYPOTHESIS 
 Inhalation exposure to occupational levels of dry MWCNT will have a negative 
impact on lung health. This hypothesis will be addressed in the following specific aims. 
1.4.2 AIM 1 
Design, develop, and test a dust generator capable of creating occupational 
levels of dry MWCNT. Key features of a nanotube dust generator for investigation of the 
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health effects of inhaled MWCNT in rodents should include 1) the ability to reproducibly 
produce an occupational concentration of MWNCT; 2) the capacity to maintain airborne 
MWCNT concentrations within the target range for at least 4 hours a day; 3) the ability 
to generate a respirable dust from a mass of commercially available MWCNT without 
damaging the nanotubes; and 4) the incorporation of safety measures to protect the 
operator from nanotube exposure. 
1.4.3 AIM 2 
 Develop a mouse model to investigate occupational exposure to MWCNT in 
order to investigate pulmonary toxicity and potential mechanisms of MWCNT-induced 







METHODS AND MATERIALS 
2.1 EXPERIMENTAL DESIGN 
 In order to assess the pulmonary toxicity of occupational levels of inhaled 
MWCNT in mice, we first designed, developed and tested a dust generator constructed 
on the ECU campus.  This generator was then used to expose mice to either a dry dust 
of MWCNT at a concentration of 37,000 particles/cm3 via nose-only exposure or to air 
only for four hours per day, five days a week, for two weeks. The mice were euthanized 
at 1, 3, 7, 10, 14, 28, and 84 days post-exposure for time course studies or at 14 days 
post-exposure for the strain comparison.  Multiple specimens were collected for 
analysis, including bronchoalveolar lavage (BAL) fluid from the right lung to determine 
changes in lung cellularity and protein levels as an index of lung injury. The right lung 
was also collected in order to measure collagen levels. The left lung was fixed for 
histological assessment.  
2.2 ANIMALS 
Four week old male C57BL/6 (B6), DBA/2J (D2), and A/J mice (Jackson 
Laboratories, Bar Harbor, ME) were provided with standard mouse chow and water ad 
libitum. Mice were housed three to a cage with a 12 hour light/dark cycle and acclimated 
for 5 days in the ECU vivarium prior to any experimentation. Mice were randomly 
assigned to experimental or control groups and conditioned in the exposure restraints 
for increasing times each day the week before the study began. All procedures and 
animal handling methods were approved by the East Carolina University (ECU) 




2.3 MWCNT DUST GENERATION AND EXPOSURE 
The MWCNT used were a kind gift from Dr. James C. Bonner of North Carolina 
State University, originally obtained from Helix Material Solutions [109].  Physical and 
chemical analysis of the MWCNT were provided by the manufacturer. MWCNT dusts 
were produced with a dust generator built in-house using a starting mass of 
approximately 0.75 mg MWCNT with addition of about 0.25 mg daily to achieve a daily 
average airborne concentration of 37,000 particles/cm3 over four hours. Particle 
concentration is an essential dose metric for nanomaterial exposure since it can be 
measured relatively easily and tracked over time [136]. Mice were exposed to either 
medical grade breathing air from a tank as controls or MWCNT suspended in medical 
grade breathing air at a rate of 2L/min per day for four hours per day, five days per 
week for two weeks. At the conclusion of the exposure period, mice were removed from 
the restraints, observed carefully for any signs of distress and returned to their cages 
and the vivarium with free access to food and water. 
Particle concentration was measured with equipment from TSI (Shoreview, MN) 
using an aerodynamic particle sizer (APS) (model 3321) which measures particles 
larger than 500nm, an electrostatic classifier (model 3080) which is used in conjunction 
with a nano water-based condensation particle counter (CPC) (model 3788) to measure 
particles smaller than 500 nm. The particles first pass an impactor that removes any 
large particles. Then, any existing charge is removed from the particles and a new 
charge is applied that scales with the size of the particle where larger particles are more 
highly charged. These charged particles can then be separated by charge such that 
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only particles of a known size are able to leave the classifier. These particles then enter 
the CPC where water is condensed around the particles so that they can be detected by 
a laser and counted. This information about particle size and the number of particles is 
then combined by a computer program to give a count of how many particles are found 
in the sample for each size. The APS measures particle sizes from 0.5 µm to 20 µm. 
The APS uses a time of flight method to measure aerodynamic particle size and counts 
the number of particle for each size. The vast majority of particles counted in this study 
were below 0.5 µm so the APS data was not used. 
2.4 TISSUE COLLECTION AND PHENOTYPING 
Collection of tissues 
Following exposure, the mice were anesthetized with a weight based 
intraperitoneal injection (0.02 ml/gram of body mass) of tribromoethanol and euthanized 
via thoracotomy and exsanguination at 1, 3, 7, 10, 14, 28, and 84 days post-exposure 
for time course studies or 14 days post-exposure for strain comparison studies. Blood 
was drawn from the right ventricle and collected in serum separator tubes to obtain 
serum samples. Bronchoalveolar lavage (BAL) was conducted on the right lung only by 
clamping the left bronchus to prevent inflation of the left lung, followed by insertion of an 
18 gauge angiocath into the trachea.  The right lung was lavaged four times with 
separate aliquots of 26.25 ml/kg cold Hank’s Balanced Salt Solution (HBSS).  The first 
BAL return was kept separate from the subsequent returns for protein analysis.  All BAL 
fluid was kept on ice until and during processing. The right lung was removed and snap 
frozen in liquid nitrogen for later measurement of lung collagen content.  The left 
bronchus was then unclamped and wedged with an 18 gauge angiocath to inflate and 
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fix the left lung with formalin. Additional organs including the heart, liver, kidneys, and 
spleen were snap frozen in liquid nitrogen, but were not analyzed in this study.  
Measurement of Lung Permeability 
Total protein was measured in BAL fluid from the first return as an index of lung 
permeability and injury using a Bradford assay (Bio-Rad, Hercules, CA) according to 
manufacturer’s instructions.  All BAL fluid was centrifuged at 500 * g for 10 minutes to 
pellet the BAL cells. The supernatant from the first BAL return was drawn off and frozen 
at -70C until protein measurements were made. Briefly, Protein Assay solution was 
diluted 1:5 in ultrapure water.  50 µL of BAL fluid was added to 2.5 mL working solution 
of protein assay reagent in 4.5 mL cuvettes. The cuvettes were inverted to mix the 
sample and reagent, allowed to incubate at room temperature for 15 minutes, and then 
read at 595 nm on a spectrophotometer (Beckman Coulter DU 730, Pasadena, CA). A 
set of bovine serum albumin (BSA) standard protein concentrations at 0, 62.5, 125, 250, 
500, 1000 µg/mL was run concurrently and the standard curve generated was used to 
calculate sample protein concentrations. 
Bronchoalveolar Lavage Cell Counts 
The cellular profile of bronchoalveolar lavage was used as a measure of lung 
inflammation.  After centrifugation, supernatant from BAL returns 2-4 were discarded 
and cells from all BAL returns were pooled for each animal in 1 ml of HBSS. The total 
number of cells recovered were counted on a hemocytometer using phase microscopy 
(Leica DM 4000 B, Wetzlar, Germany). A volume of the cell suspension from each 
animal containing 20,000 cells was pipetted in to a cytofunnel, placed in a cytofuge 
(Shandon Cytospin3, Thermo Fisher Scientific; Waltham, MA) and spun onto slides. 
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The slides were allowed to dry overnight, then stained with a three step stain set 
(Richard-Allan, Kalamazoo, MI) for differential cell counts. 300 cell per slide/sample 
were differentiated based on standard morphological criteria using bright field 
microscopy.  
Lung Collagen Content 
The right lung was used to measure soluble collagen as an indication of 
structural remodeling within the lungs. The right lung was homogenized in 2 ml of 
Radioimmunoprecipitation assay (RIPA) buffer on ice. The lung slurry was centrifuged 
at 10,000 * g at 4 degrees C to remove cell membranes. 100 µL of the lung homogenate 
supernatant was added to 500 µL Sircol dye (Biocolor, Carrickfergus, UK) and 
incubated at room temperature for 30 minutes on a shaker platform to allow dye binding 
to any soluble collagen. The samples were centrifuged at 10,000 * g to pellet collagen-
bound dye.  Excess dye was removed from the pellets and the dye was released by 
adding 1.0 mL NaOH (0.5N) and vortexing. The samples were then transferred to 1.5 
mL cuvettes and read at 540 nm on a spectrophotometer (Beckman Coulter DU 730, 
Pasadena, CA). A set of known standard concentrations were made using rat tail 
collagen (Biocolor, Carrickfergus, UK) and assayed with the samples.  Lung collagen 
content of samples was determined from the standard curve. 
Lung Histology 
The left lung was fixed in formalin for 72 hours before being cross-sectioned into 
3 pieces of approximately 5mm thickness. These pieces were placed in labelled 
cassettes and stored in 70% ethanol at 4 degrees C until standard histological 
processing was conducted. The three lung sections were embedded in paraffin and two 
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five-micron sections were cut and placed per slide. Slides were deparaffinized and 
rehydrated through an ethanol gradient before being stained with Masson’s trichrome 
stain to evaluate collagen or Alcian Blue - Periodic Acid-Schiff (AB-PAS) to evaluate 
airway mucus content. Slides were cover slipped and allowed to dry before examination 
using bright field light microscopy. Scale bars and other markings were added using 
Leica Application Suite v3.8 (Wetzlar, Germany). 
Dark Field Microscopy 
In addition to making differential cell counts, BAL cells were imaged utilizing 
enhanced dark field microscopy (Cytoviva, Auburn, AL), at a magnification of 100x. 
Scale bars were added using ImageJ (Bethesda, MD). Dark field microscopy is able to 
image MWCNT more clearly than bright field microscopy due to differences in light 
scattering for MWCNT as compared to tissue. 
Statistics 
Data are presented as mean ± SEM.  Two-way analysis of variance (ANOVA) 
was used to analyze differences between treatment groups and times or between 
treatment groups and strains as appropriate, with post hoc comparisons using the 
Bonferonni method (GraphPad Prism, San Diego, CA). Significance was assumed at p 








Numerous toxicological studies of MWCNT in animals indicate a strong potential 
for pulmonary toxicity. Most toxicology studies to date have used high doses of MWCNT 
administered as a bolus, usually by way of tracheal instillation or aspiration, but these 
exposure methods produce different deposition patterns and may lead to distinctive 
pathologies as compared to natural inhalation. The ability to generate realistic 
occupational exposure scenarios is important for development of relevant animal 
models to investigate health effects of MWCNT. A primary objective of this project was 
to determine whether natural inhalation of dry MWCNT at occupational concentrations 
would result in pulmonary toxicity. Other researchers have created computer controlled 
dust generators for inhalation research including Mitchell, et.al. [124], Baron [137], et.al. 
and McKinney, et.al. for NIOSH in 2008 [138]. Commercial dust generators are 
available but none of them met our parameters primarily since the available options use 
a grinding motion which could physically alter the MWCNT thereby rendering them 
different from the MWCNT to which occupational workers are exposed. Since 
commercially available dust generators did not meet our requirement of not damaging 
the MWCNT, our first specific aim was to design, build, and test a dust generator that 
could reproducibly generate occupational levels of MWCNT without damaging them at 
an average concentration of 37,000 particles/cm3. This target concentration was 
selected based on the literature about occupation concentrations in nanomaterial 




3.2 DUST GENERATOR DESIGN AND BUILD  
The NIOSH dust generator mirrored our parameters closer than any other 
options and so our design was based on this version. As shown in Figure 3.1 the 
NIOSH dust generator uses an acoustical system along with computerized feedback 
loops to produce an airborne dust for exposing animals to consistent concentrations of 
MWCNT. This system was tested and shown to produce particles at a desired 
concentration for long periods of time with little variance from the target concentration. 
These particles mirrored the characteristics of particles found in an occupational setting 
and could produce a range of reproducible concentrations while requiring minimal 





Figure 3.1: NIOSH Dust Generator.  Diagram illustrating the dust generator used by 
NIOSH including acrylic enclosure box containing the cylindrical dust chamber, flexible 
latex membranes, a speaker, and bulk dust. Air enters from the left and the speaker 
generates acoustical pressure to create dust in the dust chamber allowing the air flow to 










The ECU dust generator was built with the goal of generating an occupational 
concentration of dry MWCNT and exposing mice. Requirements for the build included 
not damaging the MWCNT in order to replicate occupational exposure since the length 
of MWCNT may be associated with their toxicity. The dust generator also needed to be 
able to operate for 4 hours per day and reproducibly generate occupational 
concentrations of airborne dust from day to day. The dust generator must also be able 
to safely contain the MWCNT in order to prevent exposure to the operator.  
The overall design of the exposure apparatus allowed air to flow from a 
pressurized tank, through a flow meter, to the control animal tower, or through a 
separate flow meter into the dust generator device where MWCNT would be entrained 
in the airflow before delivery to an animal tower. The first version of the dust generator 
(Figure 3.2) had a three inch diameter dust chamber held in place with a metal band. 
This design used a two-arm striker that spun on the shaft of an electric motor to hit the 
membrane on the bottom of the dust chamber twice per revolution of the motor, thus 
resulting in dust being entrained in the air flow through the chamber. However, the 
spinning action of the striker dragged across the membrane and tore the membrane. 
Thus, the design was changed to use a piston which minimized wear on the membrane 
and resulted in increased membrane life.  
Another design issue encountered with the original version was the ability to 
adjust the height of the dust chamber above the piston.  Because placement of the 
chamber and adjustment of height above the piston (and therefore deformation of the 




occupational concentration. Dust chamber height adjustment was necessary in order to 
change the concentration of MWCNT produced while the generator was in operation.  
Further design modifications were done in order to correct for deficiencies in the 
ability to generate and maintain occupational levels of airborne MWCNT.  These 
changes included increasing the diameter of the dust chamber from 3 inches to 6 inches 
in order to increase the surface area of the membrane and increase the concentration of 
MWCNT, as well as changing the material for piston sleeve from titanium to nylon to 
increase durability. This last change resulted in reduced wear and noise and gave us 





Figure 3.2: ECU Dust Generator, Version 1.  Original version of the ECU dust 
generator showing the two-arm striker, 3 inch dust chamber, rail for height adjustment, 
metal band and membranes. The two arm striker led to issues with tearing of the bottom 
membrane when in use. The rail for height adjustment and the metal band holding the 
dust chamber in place did not allow for accurate adjustments to be made from day to 











 As shown in Figures 3.2-3 the ECU dust generator was built by Gene Oakley of 
the Physics Department at ECU with the help of a group of undergraduate engineering 
students. An outer containment box of clear polycarbonate backed with PVC is sealed 
with weather stripping to prevent the MWCNT from escaping (thus meeting our criteria 
to protect the operator) and contains a motor, metal piston, and dust chamber. The dust 
chamber is a clear acrylic cylinder that has flexible latex rubber membranes on either 
end held in place by rubber O-rings. The top membrane can be easily removed in order 
to add MWCNT to the chamber. The chamber is mounted on a metal rail that allows 
height adjustments to be made to the dust chamber during operation. Beneath the dust 
chamber is the piston. The motor has a speed controller with 10 major increments that 
can be adjusted to increase or decrease the speed of the piston. Air flows from a 
compressed air tank into a Y connector and then to the control animal exposure tower 
and to the dust chamber. This design allows for simultaneous delivery of air to both the 
control and experimental exposure towers meaning that both the experimental and 
control mice are exposed to air from the same tank. A flow meter measures air flow into 
the control animal tower and is maintained at 2 L/minute. Another flow meter measures 
the air entering the containment chamber and is maintained at 2.6 L/minute. This higher 
flow rate allows for removal of 0.6L/minute just outside of the containment chamber in 
order to sample the concentration of the MWCNT. Air entering the containment box via 
the tubing is fed through the dust chamber which is filled with MWCNT. The piston, with 
its speed controlled by the variable speed motor, repetitively strikes the bottom 
membrane of the dust chamber. This striking of the membrane causes the bulk MWCNT 




chamber and containment box through tubing and is delivered to the experimental 





Figure 3.3: ECU Dust Generator, final design. The two-arm striker was replaced with 
a metal piston the stroke of which is guided by a nylon sleeve. A larger, 6 inch diameter 
cylinder was used for the dust chamber. The dust chamber was held securely in place 
by attaching it to a metal plate that is mounted on a threaded post that produces a 1 mm 
change in height per revolution. This modification to the height control mechanism 
allowed consistent placement and fine adjustment of the dust cylinder. Clean air from a 
tank enters the dust chamber through a regulator. The piston creates a dust within the 
dust chamber from the bulk MWCNT and the dust is then entrained in the air stream 









3.3 DUST GENERATOR TESTING 
Testing was performed to determine the capacity of the dust generator to 
produce a consistent occupational level of dry MWCNT dust. Airflow, amount of 
material, dust chamber height, and motor speed could all be adjusted with this system. 
Airflow needed to be at a rate high enough to allow proper ventilation for up to twelve 
animals but not so high that the animals would become dehydrated from dry air moving 
past their noses for four hours. Thus, airflow was set to approximately 2L/minute for 
both the control and experimental animals. The air entering the dust generation system 
was set at 2.6 L/minute with 0.6 L/minute being sampled after dust generation, but 
before delivery to the animal exposure tower, to measure the concentration of MWCNT 
in the air. The starting material was difficult to adjust during dust generation as it 
involved removing at least one membrane to add material and removing the whole dust 
chamber to remove material and was only changed at the beginning of the day unless 
serious problems arose such as the membrane coming loose or a very high or low 
concentration developed during operation. 
A starting material load of approximately 0.75 grams of MWCNTs was found to 
be effective to achieve our target particle concentration of 37,000 particles/cm3. 
Approximately 0.25 grams of MWCNT were added daily to maintain the average 
concentration. The MWCNT needed to be totally replaced every four or five days to 
prevent agglomeration of the MWCNT and maintain airborne concentrations of nano-
sized particles. Both height and motor speed could easily be adjusted while the dust 
generator was operating in order to alter the concentration of MWCNT being produced. 




The height of the dust generator was systematically adjusted during testing and a 
mark was made at an approximate position for maintaining our average particle 
concentration. The height was then adjusted before each exposure to achieve the target 
particle concentration. Small adjustments could quickly be performed during the 
exposure to maintain the concentration within the desired range. 
Motor speed changes also provided a means to alter the concentration of the 
MWCNT. The motor control unit has markings from 0 to 10 to control the speed at which 
the piston cycles. Increasing the motor speed leads to an increase in the concentration 
of MWCNT. In testing, the motor ran for 30 minute increments with samples collected 
every 5 minutes. As demonstrated in Figure 3.3 there was a linear increase from motor 
speed 4 to motor speed 9. This test was repeated going from motor speed 9 down to 
motor speed 4 to ensure that the effect was due to motor speed alone and not 
influenced by the amount of time the generator had been running and the particle mass 
within the dust chamber. As seen in the following graphs consistent concentrations were 






Figure 3.4: Effect of Motor Speed on Particle Concentration.  Motor speed tests 
were performed to assess the effectiveness of changing motor speed on particle 
concentration. A: The motor was started at speed setting 4 and the output of the dust 
generator was measured every 5 minutes for a 30 minute period. The motor speed was 
then adjusted to setting 5 and the measurements were made. This process was 
repeated until motor speed 9 was tested. B: The same test was performed but testing 
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3.4 DUST GENERATOR PRODUCTION OF OCCUPATIONAL LEVELS 
By making adjustments as needed, an occupational concentration can be 
consistently created with the ECU dust generator. Using a predetermined starting 
particle mass of 0.75 grams the concentration typically starts around 50,000 
particles/cm3 and slowly decays to approximately 25,000 particles/cm3 at the end of four 
hours (Figure 3.4). The average concentration for the ten days of exposure is 
approximately 37,000 particles/cm3 and can be attained across multiple experiments as 





Figure 3.5: Day to Day Variation in Particle Concentration Over Time. Particle 
concentration over four hours of continuous exposure is shown using a representative 
two week study showing number of particles/cm3 by minutes. Each curve on the graph 
represents one day of exposure with minutes shown on the X axis and particles/cm3 
shown on the Y axis. The first run measured room air which was typically around 1500 
particles/cm3 and the second run measured the tank air and was typically below 100 
particles/cm3. Samples with the motor turned on typically started around 50,000 
particles/cm3 and slowly decrease to around 25,000 particles/cm3 after 4 hours. Once 
the motor was turned off particle concentration returned to baseline within 5 minutes. 
Troughs and peaks can be seen where adjustments were made due to lower than 
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Figure 3.6: Reproducibility of Average Particle Numbers. Particle number 
reproducibility is shown as particles/cm3 on the Y axis for each two week exposure on 
the X axis. We were able to consistently achieve average concentrations of 
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While many animal studies indicate that MWCNT are toxic when delivered to the 
respiratory system, few have used occupationally relevant concentrations and routes of 
exposure. Other dust generators for inhalation research exist [124, 137, 138]; however, 
most were inappropriate for our purposes because they alter the physical properties of 
nanotubes. Specifically, the Mitchell version is believed to alter the physical properties 
of the CNT [138] and uses whole body exposure which may cause skin or fur 
contamination [139]. The Baron version was designed for use with SWCNT, but chops 
the particles up which is thought to reduce toxicity. Of the commercial dust generators, 
most use a grinding motion which could shorten nanotube length and diminish toxicity 
[138]. Since commercially available dust generators did not meet our requirement of not 
damaging the MWCNT and are expensive, we chose to design our own by altering and 
simplifying the NIOSH design. In order to address pulmonary toxicity of MWCNT in a 
realistic occupational scenario we designed, built, and tested a dust generator that met 
the criteria of being able to reproducibly generate occupational levels of MWCNT 
without causing damage to the nanotubes, while protecting the operator from exposure 
to high concentrations of MWCNT.  
We found that the ECU dust generator is capable of producing MWCNT 
concentrations in our target range by adjusting the height of the dust chamber or speed 
of the piston. The motor/piston speed correlates to changes in particle concentration in 
a nearly linear fashion. Another possible technique to control particle concentration is by 
altering airflow. We chose to use a rate of 2 L/min based on common practice in the 
field of inhalation toxicology; however, an estimate of the ventilatory requirements for 12 




allow more particles to build up in the chamber and produce increased particle 
concentrations for delivery to the animal chamber.    
Compared to the NIOSH dust generator the ECU dust generator lacks computer 
feedback loops meaning that it was less expensive to build but also that it requires 
significantly more operator attention and intervention in order to produce these desired 
concentrations. Unlike the NIOSH dust generator which maintains desired 
concentrations more consistently, the ECU concentrations decay over time apparently 
due to loss of particle mass. Although we did not add particles during the daily exposure 
period because of the necessity of stopping the exposure, we did observe that adding a 
relatively greater mass before each daily exposure resulted in higher particle 
concentrations.  Thus, it is possible that a design alteration that allows for easier 
addition of particles during exposure could lead to more consistent exposure levels.  
Alternatively, more frequent or greater operator adjustments would likely increase 
consistency. On the other hand, workers in an occupational setting are unlikely to be 
exposed to a consistent concentration of MWCNT.  Rather, particle concentration varies 
with the specific process or activity in an occupational setting [32].  We therefore chose 
to allow the particle concentration to decay over time to more closely mimic 




TIME COURSE AND STRAIN COMPARISON 
4.1 INTRODUCTION 
Human health effects associated with exposure to MWCNT have not been 
documented to date.  However, concerns about potential adverse health effects due to 
similarities between MWCNT and asbestos have been raised, and numerous animal 
studies support these concerns. As previously discussed, most animal studies on 
pulmonary responses to MWCNT exposure have used high bolus doses and/or non-
physiological routes such as intratracheal instillation or aspiration. Not surprisingly, 
many of these studies found various pathologies including inflammation and 
granulomas.  Yet such pathology may be a result of the delivery route and high dose.  In 
order to assess risks associated with occupational exposures, it is important to use 
realistic exposure scenarios.   
Therefore, we developed a mouse model to investigate pulmonary toxicity of 
MWCNT using the dust generator we developed to deliver a dry dust of MWCNT at an 
occupational concentration for inhalation. First, a time course study was conducted to 
determine the time of peak pulmonary effects induced by inhalational exposure to 
MWCNT. For this experiment, C57BL/6J male mice were used because it is the most 
commonly used strain in the literature and allowed us to compare our findings with other 
studies on the pulmonary effects of MWCNT. Mice were exposed to air only (control) or 
to an average concentration of 37,000 particles/cm3 of dry, inhaled MWCNT for 4 
hours/day, 5 consecutive days/week, for two weeks. The mice were sacrificed 1, 3, 7, 




protein), inflammation (BAL differential cell counts), fibrosis (lung collagen content), and 
other lung pathologies (histological examination), as well as particle retention (dark field 
microscopy) were made.  
As most environmentally induced lung diseases also have a genetic susceptibility 
component, we also compared three diverse strains of mice to determine if there may 
be a genetic basis for differential responses to inhaled MWCNT.  For this set of 
experiments, we exposed A/J and DBA/2J male mice to dusts of MWCNT as described 
for C57BL/6J mice.  Mice were euthanized 14 days post-exposure and the same end 
points were examined. 
4.2 RESULTS 
4.2.1 TIME COURSE 
BALF protein levels, a measure of lung vascular permeability indicating lung 
injury, were not significantly different between MWCNT-exposed and air control mice at 
any time point (Figure 4.1), nor were there significant differences between time points. 
Total cell numbers recovered from BALF were significantly elevated at 28 days and 
showed a trend towards increased numbers at 1 day post exposure in MWCNT 
exposed mice compared to air controls (Figure 4.2). However, there was considerable 
variation in cell numbers in both air and MWCNT-exposed mice between time points.   
Similarly, alveolar macrophages were elevated at 28 days post exposure in MWCNT 
exposed mice with a trend toward increases at one day (Figure 4.3A). Macrophages 
made up the majority (78-98%) of the cell numbers and thus parallel total cell numbers. 
Monocytes were significantly elevated at 10 and 14 days post exposure in MWCNT 




in numbers across time points, absolute numbers were less than a tenth of absolute 
macrophage numbers.  Significant increases in recruited leukocytes (neutrophils, 
eosinophils, and lymphocytes) were not observed in response to MWCNT exposure at 
any time point. (Figures 4.3 D-F).  Both neutrophils and eosinophils were present in low 
numbers in both MWCNT and air-exposed mice intermittently, particularly during the 
first 10 post-exposure days.  Again there was substantial variation in numbers across 
time points. Lymphocytes were present more consistently and showed trends toward 
elevation in numbers with MWCNT exposure at 10, 14, and 28 days post exposure.  
Lung soluble collagen levels were consistent between both treatments and time points 
and did not show any significant differences between air controls and MWCNT-exposed 





Figure 4.1: Time course of BALF protein. BALF protein was measured using the 
Bradford method. BALF protein was not elevated in MWCNT exposed mice compared 
to air control mice when tested at 1, 3, 7, 10, 14, 28, and 84 days post exposure.  Blue 
bars represent the air exposed animals and red bars represent the MWCNT exposed 
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Figure 4.2: Time course of total BALF cell numbers. Total cells expressed as 
number of cells/ml of recovered lavage fluid increased at 28 days post exposure in 
MWCNT exposed mice compared to air exposed mice. Blue bars represent the air 
exposed animals and red bars represent the MWCNT exposed animals. n = 5 for air 
exposed mice at 14 day post exposure and n = 6 for all other groups. * indicates p < 
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Figure 4.3: Time course of BAL Cellular Profile. For all graphs, cell numbers are 
expressed per ml of recovered lavage fluid. A) Macrophages increased at 28 days post 
exposure in MWCNT exposed mice compared to air control mice. B) Monocytes were 
significantly increased at 10 and 14 days post exposure for MWCNT exposed mice 
compared to air controls. C) Epithelial cells were increased at 3 days post exposure in 
air control mice compared to the MWCNT exposed mice. D) Neutrophil numbers were 
low and did not significantly change with regard to treatment or time point. E) Eosinophil 
numbers did not show any significant changes. F) Lymphocytes numbers tended to be 
elevated in MWCNT-exposed mice compared to air control, but these changes did not 
reach statistical significance. Blue bars represent the air exposed animals and red bars 
represent the MWCNT exposed animals. n = 5 for air exposed mice at 14 day post 
exposure and n = 6 for all other groups. * indicates p < 0.05 compared to air controls 












Figure 4.4: Time course of lung collagen content. Soluble lung collagen was 
measured in homogenized right lung using the Sircol Assay. Lung collagen content was 
not increased at any time point and did not change with treatment. n = 5 for air exposed 
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Despite a lack of collagen response to MWCNT exposure, when the lung was 
homogenized for the collagen assay, the MWCNT exposed animals had a visible gray 
layer in the membrane pellet at every time point.  
Histological lung sections were stained with Masson’s Trichrome to allow 
visualization of collagen (blue), or Alcian Blue-Periodic Acid Schiff (AB-PAS) to allow 
visualization of mucus containing cells. Overt differences between air- and MWCNT-
exposed mice were not observed at any time point. In fact, all sections appeared to 
have normal airway and parenchymal lung structure and cellular content. However, all 
sections from MWCNT-exposed mice had numerous alveolar macrophages containing 
black particles, while such particles were not seen in any air control lung sections 
(Figure 4.5).   
The observation that MWCNT may have accumulated in alveolar macrophages 
in both BAL cells and histological sections, led us to have BAL cells imaged with dark 
field microscopy to validate the presence of MWCNT. As seen in Figure 4.6 nanotubes 
were present in macrophages recovered in BALF from MWCNT exposed animals for all 
time points including out to 84 days post exposure. Histological sections were also 
imaged using dark field microscopy, but nanotubes were not observed in lung tissues 





Figure 4.5: Lung Histology. Representative images from formalin fixed, paraffin 
embedded left lung sections show MWCNT-laden alveolar macrophages (arrows) at 1, 
3, 7, 10, 14, 28, and 84 days post exposure to MWCNT. Alveolar macrophages in air 
exposed mice did not contain any visible particles at any time point (1 day post air 
exposed lung shown on top left).  All slides shown are stained with AB-PAS. Scale bar 








Figure 4.6: Dark field microscopy of BAL cells. Dark field images demonstrate that 
MWCNT are present in alveolar macrophages recovered from BALF at all time points 
post MWCNT exposure, but not in air controls. MWCNT appear as blue/white fibers and 
particles that are retained in alveolar macrophages for at least 84 days post exposure. A 
1 day post exposure air control image is shown (top left) for comparison. Scale bars are 










4.2.2 STRAIN COMPARISON 
Numerous studies have shown that susceptibility to environmentally induced lung 
disease phenotypes can be strain dependent. For example, fibrotic responses are 
known to differ between strains after exposure to V2O5 [140], asbestos [141], bleomycin 
[142], and silica [143]. In fact, the C57BL/6J strain of mice is known to be susceptible to 
bleomycin- and asbestos-induced fibrotic responses, but is resistant to V2O5-induced 
pulmonary fibrosis. In order to determine whether the lack of pulmonary responses to 
inhaled MWCNT that we observed in the time course study described above may have 
been because C57BL/6J mice are genetically resistant, two additional strains of mice, 
DBA/2J and A/J, were then exposed to MWCNT at the same average concentration as 
previously described and sacrificed at 14 days post exposure. Data from C57BL/6J 
mice at the 14 day time point above was compared to A/J and DBA/2J data. The 14 day 
time point was chosen because it is a time point at which fibrotic, as well as some 
cellular responses have been observed after nanotube exposure [98], plus we observed 
an elevation of monocytes at this time. A/J and DBA/2J strains were chosen because 
they are genetically very different from the C57BL/6J mice and from each other, which 
should allow detection of differential genetic susceptibilities. Additionally, DBA/2J mice 
are highly susceptible to V2O5-induced pulmonary fibrosis [140], while A/J mice are 
known to be predisposed to Th2-like responses which are thought to contribute to 
fibrotic responses [144].  
Similar to the responses seen in C57BL/6J at 14 days post exposure, A/J and 
DBA/2J mice did not exhibit significant differences in protein levels, total cells, or 




trends were observed. As seen in Figure 4.6, BALF protein was not significantly 
increased in MWCNT exposed mice compared to air control mice at 14 days post 
exposure in DBA/2J or A/J mice. However, in A/J mice MWCNT exposure induced a 
trend towards elevated BALF protein levels compared to the air controls, although A/J 
mice had lower protein levels than C57BL/6J or DBA/2J mice in general.  Total BAL 
cells were not significantly increased in any strain of mice exposed to MWCNT (Figure 
4.7). Yet in contrast to protein levels, total cell counts (Figure 4.7) and several specific 
cell types (Figure 4.8) were elevated in DBA/2J mice after MWCNT exposure, although 
these increases were not statistically significant. Specifically, DBA/2J mice exposed to 
MWCNT showed a trend of increasing macrophages that was not seen in C57BL/6J 
and A/J mice (Figure 4.8A). Monocytes were significantly increased at 14 days post 
exposure for C57BL/6J MWCNT exposed mice compared to air controls and were 
slightly elevated in DBA/2J mice (Figure 4.8B). Epithelial cells, neutrophils, and 
eosinophils did not significantly increase in MWCNT exposed mice compared to air 
controls in any of the three strains yet DBA/2J mice had a non-statistically significant 
increase in neutrophils, and eosinophils were observed in both air and MWCNT-
exposed mice of the A/J and DBA/2J strains (Figure 4.8C-E). Lymphocyte numbers in 
MWCNT-exposed C57BL/6J mice were significantly elevated, however, C57BL/6J mice 
had a higher number of lymphocytes in air-exposed mice compared to the other strains 
as well (Figure 4.8F). Finally, there were no differences in lung collagen content with 






Figure 4.7: BALF protein in three strains of mice. C57BL/6J (B6), DBA/2J (D2), and 
A/J strains of mice exposed to inhaled MWCNT or air did not have statistically 
significant differences in BALF protein levels at 14 days post-exposure. However, A/J 
mice showed a trend towards increased BALF protein in MWCNT-exposed mice that 
nearly reach significance. BALF protein was measured using the Bradford method. n = 
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Figure 4.8: Comparison of total BAL cells across three strains of mice. Total cell 
numbers were not significantly increased at 14 days post MWCNT exposure compared 
to air controls in C57BL/6J (B6), DBA/2J (D2), or A/J mice. Yet, D2 mice exposed to 
MWCNT did show a trend of increasing cells as compared to the air exposed mice. n = 
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Figure 4.9: Differential BALF cell counts in three mouse strains.  All graphs (A-F) 
represent cell numbers recovered from BALF at 14 days post exposure in C57BL/6J 
(B6), DBA/2J (D2), and A/J mice. A) Although alveolar macrophage numbers did not 
significantly increase in MWCNT exposed mice compared to air control mice in any of 
the three strains, there was a trend toward increased numbers in D2 mice exposed to 
MWCNT. B) Monocytes were significantly increased at 14 days post MWCNT exposure 
in B6 mice compared to air controls. C) Epithelial cell numbers varied somewhat by 
strain, but were not significantly altered by exposure in any strain. D) Neutrophil 
numbers were very low and were observed sporadically in D2 MWCNT-exposed mice 
and A/J air-exposed mice. E) Eosinophil numbers were also low and observed 
sporadically in D2 and A/J mice. F) Lymphocyte numbers were significantly elevated in 
MWCNT-exposed B6 mice compared to air control mice, while D2 mice showed a 
similar trend with lower numbers, but A/J mice did not. n = 5 for air exposed B6 mice 
and n = 6 for all other groups. ** indicates p < 0.01 compared to air controls within 










Figure 4.10: Strain comparison of lung collagen content. Soluble lung collagen 
levels were not changed at 14 days post exposure with regard to exposure or strain.   
[C57BL/6J (B6), DBA/2J (D2), or A/J mice]. n = 5 for air exposed B6 mice and n = 6 for 













































Although no dark field microscopy was performed on these strains, alveolar 
macrophages were observed to contain MWCNT both histologically and in cell pellets 
recovered in BALF.  Likewise, a gray layer in the membrane pellet of homogenized lung 
tissue was present in all strains. As in C57BL/6J mice, histological lung sections from 
both air and MWCNT-exposed A/J and DBA/2J mice had normal structure and showed 
no evidence of inflammation, fibrosis, or increased mucus production at 14 days post- 
exposure; however, MWCNT were visible within alveolar macrophages at high 





Figure 4.11:  Histological lung sections from three strains of mice. Histology 
images showing dark MWCNT in alveolar macrophages (arrows) of C57BL/6J (B6), 
DBA/2J (D2), and A/J mice 14 days after MWCNT exposure, but not after air exposure. 











Pulmonary exposure to MWCNT has been reported to result in several 
pathological phenotypes in mice. However, many of these reports employed high-dose, 
bolus techniques to deliver the nanotubes. Use of these unrealistic exposure scenarios 
can produce biological responses that are vastly different from responses to more 
realistic exposures. Because several thousand tons of MWCNT are being produced 
yearly to meet the wide variety of applications, occupational exposure presents a 
potential health risk for workers. Thus, one of the goals of this project was to determine 
whether exposure to occupational levels of MWCNT through inhalation of a dry dust 
results in pulmonary toxicity.  
We therefore developed a mouse model to examine pulmonary outcomes over a 
three-month time course after exposure to an intermediate occupational concentration 
of MWCNT. Our data suggests that at the concentrations and short duration of 
exposure we used, there are minimal acute effects on the respiratory system. 
Specifically, the lack of increases in protein levels indicates that lung permeability was 
not increased by MWCNT exposure and the epithelial-endothelial barrier in the lungs 
remained intact. Furthermore, significant increases in recruited inflammatory cells 
(neutrophils, eosinophils and lymphocytes) were not observed in the time course. 
However, in the strain screen, lymphocytes and monocytes were increased in C57BL/6J 
mice which may be the result of a mild immune response to inhaled MWCNT. Other 
studies found a variation of lung immune responses depending on the nanoparticle 
inhaled [145], a modulation of the immune response when using inhaled MWCNT in 




lung inflammation [124]. In the time course, we observed a significant increase in 
epithelial cells at 3 days post exposure in air control mice.  This cause of this 
anomalous increase is unknown but may have resulted from unknown exposures in the 
vivarium, a response to dry air during exposure, or inconsistencies in the lavage 
technique. 
Histological examination of lung tissue did not show any overt effects of MWCNT, 
except the presence of particle-laden alveolar macrophages. This may be interpreted as 
the macrophages acting to defend the lungs from foreign materials by phagocytosing 
them. However, the lack of macrophage clearance of CNT, as evidenced by their 
presence out to 84 days post-exposure, may indicate a MWCNT-induced effect on 
macrophage function. This may have important ramifications for secondary exposures 
after exposure to MWCNT.  
While the same data were used for C57BL/6J mice in the time course and strain 
screen, the p values for the cell counts changed due to changes in overall power and 
variance of the data sets. Thus, in the time course, lymphocytes were not significantly 
elevated for MWCNT exposed C57BL/6J mice at 14 days, yet significance was reached 
when analyzing them with the A/J and DBA/2J data.  
One of our initial objectives was to use genetic mapping to identify susceptibility 
factors and potential mechanisms of observed pulmonary phenotypes.  Unfortunately, 
under the conditions used for the current studies we did not observe a significant 
phenotype suitable for genetic mapping and thus did not pursue mapping objectives.  
None-the-less, we did see exposure-dependent trends in different strains of mice that 




effects). Most studies of respiratory exposure to MWCNT have been conducted in 
C57BL/6 mice or outbred strains, thus our observation of differential responses, 
although not statistically significant, may indicate that genetic background plays an 
important role in responses to inhaled MWCNT.  The use of higher concentrations or 
more prolonged exposures in future studies could produce significant inter-strain 
differences.  
In summary, we did not find evidence of acute pulmonary effects from MWCNT 
at the concentration and duration of exposures used, with the exception of retention of 
MWCNT in alveolar macrophages.  On the other hand, we did observe some trends that 
may suggest genetic susceptibility to MWCNT-induced pulmonary deficiencies with 





5.1 SUMMARY OF STUDY 
This study was designed to investigate the pulmonary toxicity of inhalation 
exposure to occupational levels of MWCNT in mice. To accomplish this objective, a dust 
generator capable of reproducibly delivering occupational levels of dry MWCNT was 
successfully built and used to expose mice. At the exposure concentration and duration 
that was used, there were no signs of overt toxicity. However, there were minor 
changes in the cellular profile recovered in lavage fluid, which varied over time and with 
strain suggesting that multiple factors likely influence pulmonary responses to MWCNT 
including physicochemical properties of the nanotubes, as wells as dose, duration of 
exposure, and genetic or host factors. Notably, the persistence of MWCNT in alveolar 
macrophages to three months post-exposure suggests that even at low doses, MWCNT 
can alter macrophage function and reduce clearance which could have an important 
impact on innate host-defense mechanisms. 
5.2 DISCUSSION 
 This study designed, built, tested, and deployed a dust generator capable of 
producing dusts with consistent levels of MWCNT to facilitate the study of pulmonary 
effects of inhaled MWCNT in mice. Using this dust generator we found no overt signs of 
toxicity in mouse pulmonary tissue other than evidence of retained nanotubes in 





 Toxicity is a complex process with multiple factors including physical and 
chemical properties of the agent; characteristics of the exposure including the route, 
dose/concentration, and duration; biopersistence of the agent; aggregation of the agent; 
and multiple host factors. Of particular concern with nanomaterials are the physical and 
chemical properties of the material including size, surface area, agglomeration, shape, 
surface chemistry, chemical composition, rigidity, etc. In terms of pulmonary pathology, 
key considerations include deposition, biopersistence, exposure duration, and 
interaction with other body systems [136]. MWCNT toxicity appears to be a result of 
deposition and retention [147]. The cellular dose received is a function of multiple 
properties including the particle size, shape, density, and charge however additional 
factors such as metabolism may confound the cellular dose. Unfortunately, 
measurement of the cellular dose is difficult, costly, and generally not possible for most 
studies [148]. 
 Our mild results could be due to several factors. First, the duration of exposure 
we used was 10 days at a rate of 5 days per week which is considerably shorter than 
that used by others who observed more severe effects. Our exposure time of two weeks 
is about 2% of a mouse’s life span and may have simply been inadequate to observe 
more significant effects. Pauluhn found that inhalation exposure over a 1 month period 
(using 11 and 241 mg/m³) with a post exposure period of 3 months may be necessary in 
order to elicit effects specific to the tested nanoparticle [149]. Although our post-
exposure time of 84 days was close to three months, the exposure duration we used 
was less than half of the 1 month exposure period described by Pauluhn. The effects of 




years or decades. Our finding that MWCNT were retained in the mouse lung tissue for 
at least 84 days, suggests that repeated or chronic exposure could lead to accumulation 
of material and long-term pulmonary effects such as impaired lung clearance or deficits 
in host defense mechanisms.    
 Pulmonary toxicity in rats exposed to MWCNT by inhalation was shown to be a 
product of both time and concentration [61]. Our chosen concentration was well within 
the occupational range measured in production and processing facilities [32]. As 
previously mentioned, numerous studies that have reported lung pathology used 
drastically higher particle concentrations.  A higher airborne concentration would have 
likely elicited greater responses; however, our objective was to determine effects of 
exposure to occupational levels of MWCNT, not to demonstrate toxicity without regard 
to dose/concentration.    
 The physicochemical properties of MWCNT may also influence toxicity [21, 132, 
150, 151]. Effects could be due to chemical functionalization or residual metal 
contamination from manufacturing of the MWCNT, or to different physical properties 
such as length and rigidity [79, 152]. One possible explanation for our mild results is that 
the nanotubes we used had only low levels of chemical contaminants such as metals.  
Studies have found that MWCNT with iron impurities induced ROS while MWCNT 
without iron did not [153] as did nickel contamination [154]. . Nickle oxide nanoparticles 
induced oxidative stress in rat lungs while titanium oxide nano and fine particles did not, 
thus appearing to suggest that the presence of nickel is a factor in oxidative stress that 
could lead to inflammation and cellular damage [152, 159]. Previous studies using the 




chemical composition; however, a different measurement methodology found a much 
lower percentage [155]. An in vitro study of lung epithelial cells showed that pristine 
MWCNT can demonstrate biopersistence in these cells without having long term 
consequences [54].  
 The length, diameter, and rigidity of nanotubes all appear to be factors in causing 
inflammation [9, 21, 156].  Nagai, et al., reported that the rigidity of MWCNT plays a 
crucial role in determining mesothelial injury [79]. However, as seen in the dark field 
images of alveolar macrophages that have phagocytosed MWCNT (Figure 4.6), the 
longer fibers appear to be curved and flexible.  Additionally, many of the ingested 
particles appear to be short, although this may be an artifact of processing.  The 
MWCNT we used were reported to range from 0.3 – 50μm in length; however, we did 
not have the particles analyzed post-dust generation, so it is possible that our system 
selectively generated dusts of only shorter particles or broke the longer nanotubes, 
although the latter seems unlikely. Certainly, the dust we generated was within a 
respirable size range as we observed gray material in the BAL cell pellets (presumably 
in the macrophages) from MWCNT-exposed mice, as well as in the membrane pellets 
of homogenized lung tissue.  
 Deposition and clearance of particles plays an important role in pulmonary 
responses to exposure.  We exposed mice to dry MWCNT, which were previously 
shown to have a deposition rate three times less than that of wet MWCNT although the 
dry MWCNT also had a clearance rate that was slower than for wet MWCNT (87 days 
versus 46 days) [57].  These studies support our observation of biopersistence to 84 




and subsequent lung pathology is agglomeration. Li, et al compared MWCNT inhalation 
with instillation in mice.  The inhalation group had different patterns of MWCNT 
aggregates than were observed in mice instilled with MWCNT. Furthermore, mice that 
inhaled MWCNT did not show the expected pathology that was seen in MWCNT 
instilled mice [48].  MWCNT instilled in rats with BSA as a dispersing agent were seen 
in the macrophages but without inflammatory markers. The lack of an inflammatory 
response could have been a result of protein interactions with MWCNT to induce 
phagocytosis or due to the smaller agglomerates because of the dispersing agent [59]. 
Similarly, we observed MWCNT in macrophages, but no cellular inflammation, 
suggesting that inhalation of dry MWCNT may result in improved dispersion of the 
MWCNT or smaller agglomerates that produce less inflammation and associated 
pathology. Deposition of inhaled MWCNT in the concentration range of 0.3-5mg/m3 for 
6 hours per day for either 7 or 14 days resulted in deposition weights of MWCNT of 0.2 
to 2.7 mg/kg in mice, but did not produce lung pathology [124].  Our study used a 
concentration which corresponds to a mass that is smaller than the highest 
concentrations referenced above, thus, it is expected that we also had a lower 
deposited mass.   
 Finally, the lack of any signs of lung injury or inflammation after inhalation of 
occupational levels of MWCNT may be due to immunosuppressive effects of stress on 
the mice.  A study of mice exposed to acute inescapable foot shocks found depressed 
antibody response, inhibited lymphocyte reactions, and attenuation of immune function 
[157].  Although soft restraints were used which allow animals to move their limbs and 




exposure stressed the mice and limited host defense and immune responses to 
MWCNT.   
5.3 LIMITATIONS 
This study had several limitations. First, our overall objective was to determine 
pulmonary effects of occupational levels of inhaled MWCNT.  Therefore, our dust 
generator was designed to produce occupational concentrations of MWCNT. The initial 
design did not consider the potential need for higher concentrations.  However, 
exposure to a much higher concentration of MWCNT might have resulted in obvious 
pathologies and identification of significant phenotypes on which genetic mapping could 
have been conducted. Once defined phenotypes were identified, a more focused 
experiment could have looked for early signs of these effects at occupational 
concentrations. Our study also dispersed only dry MWCNT as opposed to wet MWCNT 
which have been shown to have a significantly higher deposition rate than dry MWCNT 
[57]. This may have limited the negative impacts but is a closer model to occupational 
exposure in which the MWCNT become airborne during manufacturing, handling, 
transporting, etc. [20]. A study of occupational exposure rates showed that 2 of 6 sites 
tested were above 7 µg/m3 which was the NIOSH REL at that time [35]. NIOSH 
currently recommends exposure to no more than 1 µg/m3 of air which is the lowest 
measurable airborne concentration and is intended to protect workers long term [160]. 
We are not confident in the particle mass measurements we obtained since our 
equipment measures aerodynamic diameter which assumes spherical particles while 
MWCNT are cylindrical particles, thus making it difficult to compare our results with the 




Additionally, only short-term exposure was tested in this study. Given the observation 
that MWCNT are retained in alveolar macrophages, a longer duration of exposure may 
have resulted in further accumulation of particles and potentially pulmonary pathology. 
Additionally, we were not able to quantitate the pulmonary deposition and retention of 
MWCNT nor could we determine how similar the deposition and clearance/retention is 
between mice and humans for inhaled MWCNT under the conditions we used.  The 
MWCNT we used are likely to be low in toxicity for a number of reasons including low 
levels of metal contaminants, flexibility of the fibers, and possibly a high proportion of 
relatively short tubes. We did not try to validate that the MWCNT exiting the 
containment chamber were of the same length that we started with. Use of electron 
microscopy to examine the MWCNT before and after the dust generator could have 
addressed this limitation.  
  We were interested in MWCNT since it is one of the most widely used 
nanomaterials; however, other nanomaterial may have greater toxicity.  Furthermore, 
we only used one type of MWCNT and did not explore other MWCNT which may vary 
greatly in length, rigidity, diameter, surface area, metal contaminants, or chemical 
modifications.   
5.4 FUTURE STUDIES 
There are many questions left to answer regarding the pulmonary toxicity of 
MWCNT and other nanomaterials. Our studies are a starting point to address the 
biological effects of realistic occupational exposure scenarios. Use of a different 
nanotube/nanomaterial and/or concentration is a possible area of future study. We 
would not vary using inhalation but previous studies found variations in both 




the type of CNT, the dose of CNT, and the route by which the CNT were administered 
[124], so repeat studies using MWCNT with different properties and/or a different 
concentration may have different results. If another nanomaterial is commonly made, 
known to be dangerous at high concentrations, and is an occupational risk, we can test 
occupational levels of those materials for toxicity. Further, smaller diameters and 
increased rigidity are known to increase the toxic effects of MWCNT [161] so study of 
MWCNT that meet those criteria may find different effects at occupational levels than 
we found with our MWCNT. Since dose is a key part of toxicity, longer exposures but 
still at occupational concentration could elicit different results. Future studies could also 
be done using mice with pre-existing pulmonary pathology. Asthma is known to 
increase the effect of MWCNT on the pulmonary system [155] and other lung 
pathologies may also increase the effect of MWCNT in the lung. Asbestos exposure and 
tobacco smoke are known to interact [162, 163] and it is possible that a similar effect 
will occur with MWCNT. Similarly, secondary exposure is an area that needs to be 
studied. There are inconclusive data that suggest bacterial lipopolysaccharide (LPS) 
combined with nanotubes may worsen the effects compared to nanotubes alone and 
appear to indicate that pre-existing inflammation increases risk [86, 164]. Further study 
of LPS exposure as a secondary exposure or to other substances is warranted for 
occupational concerns because workers who have already been exposed to nanotubes 
may also be exposed to other things that cause toxicity. Because we found that 
MWCNT are retained in the lung, and in macrophages in particular, secondary insults to 




Further study of macrophages themselves is an important area to study because 
the presence of MWCNT may alter or hinder their activity. Assessing macrophage 
phenotype is possible through PCR looking for markers of M1 or M2. Phagocytosis can 
be assayed using flow cytometry to determine how well macrophages are able to 
phagocytose particles. In vitro work specifically related to macrophages is also an area 
for future work. 
5.5 CONCLUSION 
The results of this study might seem like good news for people working with 
MWCNT since we did not find evidence of overt pulmonary pathology. Unfortunately, 
this may not be the case since we did find biopersistence to the limits of our study. Had 
we extended the length of our exposures we may have seen pathology as a result of a 
lag time between exposure and pathology similar to the lag time between exposure to 
asbestos and diseases related to asbestos exposure. We did test at a level well above 
the current NIOSH recommendation of an exposure rate of no more than 1 µg/m3 of air 
which is the lowest measurable airborne concentration and is intended to protect 
workers long term [160]. We successfully built and tested a dust generator that can be 
used for future studies looking at longer exposures, different MWCNT, alternate 
concentrations, and co-morbidities that might result in the earlier development of 
pulmonary pathologies. Given the wide spread and growing use of MWCNT a clear 
understanding of the possible risks from exposure to MWCNT, particularly via 
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